Oral delivery of engineered food‐grade LAB strains with human Elafin gene, which was found to be diminished in IBD patients, to mice, resulting in restored colon physiological functions and gut homeostasis, reduced acute and chronic gut inflammation, suggesting a useful treatment for IBD. The gene discussed is PI3; the disease is inflammatory bowel disease.